Literature DB >> 5764028

Control of heparin therapy. Sensitivity of the activated partial thromboplastin time for monitoring the antithrombotic effects of heparin.

S Zucker, M H Cathey.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1969        PMID： 5764028

Source DB:  PubMed          Journal:  J Lab Clin Med        ISSN： 0022-2143


× No keyword cloud information.
  8 in total

1.  Expression and characterization of wild-type TFPI and the [P151L]TFPI mutant in insect cells.

Authors:  Elmar Thyzel; Sabine Siegling; Thomas Brinkmann; Knut Kleesiek; Christian Götting
Journal:  Mol Cell Biochem       Date:  2006-02       Impact factor: 3.396

2.  A modified whole blood partial thromboplastin test for the assessment of heparinization.

Authors:  P K Ray; D Abbott
Journal:  Can Med Assoc J       Date:  1973-06-23       Impact factor: 8.262

3.  [Partial thromboplastin time. Change in time by alteration of the concentration of single blood coagulation factors using reagents from various producers. Effect of heparin on partial thromboplastin time].

Authors:  R Averdunk; J S Braun
Journal:  Blut       Date:  1972-06

4.  Monitoring heparin therapy with the activated partial thromboplastin time.

Authors:  R K Stuart; A Michel
Journal:  Can Med Assoc J       Date:  1971-03-06       Impact factor: 8.262

5.  Heparin and warfarin anticoagulation intensity as predictors of recurrence after deep vein thrombosis or pulmonary embolism: a population-based cohort study.

Authors:  John A Heit; Brian D Lahr; Tanya M Petterson; Kent R Bailey; Aneel A Ashrani; L Joseph Melton
Journal:  Blood       Date:  2011-09-02       Impact factor: 22.113

Review 6.  Antithrombotic drugs: part I.

Authors:  A S Gallus; J Hirsh
Journal:  Drugs       Date:  1976       Impact factor: 9.546

7.  Unsuitability of evacuated tubes for monitoring heparin therapy by activated partial thromboplastin time.

Authors:  A D Heyns; D J van den Berg; P H Kleynhans; P W du Toit
Journal:  J Clin Pathol       Date:  1981-01       Impact factor: 3.411

Review 8.  Heparin pharmacokinetics and pharmacodynamics.

Authors:  R J Kandrotas
Journal:  Clin Pharmacokinet       Date:  1992-05       Impact factor: 6.447
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.